• Population-level epidemiology and outbreak surveillance establish a unifying framework to quantify burden, transmission, and risk across poliomyelitis, Q fever, brucellosis, streptococcal infections and accidents, guiding public health action. Evidence draws from many studies [1], [3], [7], [9], [11], [14], [15], [16], [19].

• Standardization and cross-study comparability through disease classification and coding enable uniform mortality, disease mapping, and inter-hospital research across mid-20th century epidemiology [17], [18], [20].

• Quantitative methods in hospital epidemiology: defining admission severity, prognostic biomarkers, and objective outcomes to improve prognosis and hospital surveillance [4], [5], [6], [10].

• Cardiovascular epidemiology as a core research axis: expansive study design (Framingham), mortality quantification, and critical appraisal of anticoagulant therapy in myocardial infarction [4], [5], [6].

• Infectious disease epidemiology and infection control: antibiotic resistance, poliomyelitis, Q fever, brucellosis, and streptococcal infections framed within clinical epidemiology [1], [2], [9], [11], [14], [16], [19].

• Cross-disease breadth of clinical epidemiology demonstrates methodological generality, spanning poliomyelitis, brucellosis, Q fever, streptococcal infections and accidents, highlighting the versatility of epidemiologic methods [7], [9], [11], [14], [15], [16].